Panchsheel Organics
Healthcare
531726 BSE
₹101.50
Close ·
- P/E
- 13.00
Close 4 Nov 2026 ₹101.50 −36.50 −26.4% 1Y
Start ₹138.00
Key Fundamentals
MicrocapPharmaceuticals & BiotechnologyHealthcarePrice-based figures at the close · EPS basis: Standalone · TTM
- ROCE
- 10.30%
- Debt to Equity
- 0.04
- EPS (TTM)
- ₹7.81
- Book Value
- ₹106.92
- Market Cap
- —
- P/E (TTM)
- 13.00
- P/B
- 0.95
- ROE
- 7.89%
- Dividend Yield
- 0.79%
- EBITDA
- ₹17.00 Cr
- 52W High
- ₹154.40
- 52W Low
- ₹86.10
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
59 Good
Data confidence 100/100
Category scores
- Quality
- 60
- Good
- Returns, margins, earnings quality 22% weight
- Valuation
- 73
- Strong
- Cheap vs sector & own history 24% weight
- Growth
- 40
- Weak
- Sales & profit trajectory 9% weight
- Financial Health
- 82
- Strong
- Solvency, leverage, coverage 9% weight
- Momentum
- 32
- Poor
- Trend strength, vol-adjusted 12% weight
- Ownership
- 50
- Average
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
4- Company is almost debt free.
- Stock is trading at 0.96 times its book value
- Stock is providing a good dividend yield of 3.10%.
- Company has been maintaining a healthy dividend payout of 18.0%
Weaknesses
1- Company has a low return on equity of 10.3% over last 3 years.
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bearish | 11 | 7 | 1 |
| Oscillators | Neutral | 1 | 7 | 1 |
| Moving Averages | Strong Bearish | 10 | 0 | 0 |
Oscillators
Neutral
Bearish
1
Neutral
7
Bullish
1
Overall
Strong Bearish
Bearish
11
Neutral
7
Bullish
1
Moving Averages
Strong Bearish
Bearish
10
Neutral
0
Bullish
0
Key readings
- RSI (14)
- 45.62
- Neutral
- MACD (12,26,9)
- −1.53
- Bullish
- SMA (50)
- 106.76
- Bearish
- SMA (200)
- 113.48
- Bearish
As of
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.
Revenue
| 10Y | +10.34% |
|---|---|
| 5Y | +16.91% |
| 3Y | +1.28% |
| 1Y | 0.00% |
| TTM | +2.32% |
Net profit
| 10Y | +13.87% |
|---|---|
| 5Y | +17.08% |
| 3Y | −7.72% |
| 1Y | −21.43% |
| TTM | −23.59% |
Operating cash flow
| 10Y | +12.79% |
|---|---|
| 5Y | +14.87% |
| 3Y | Zero base |
| 1Y | +150.00% |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 10Y | −1.92 pp |
|---|---|
| 5Y | −5.29 pp |
| 3Y | −6.34 pp |
| 1Y | −3.74 pp |
| TTM | −5.18 pp |
Revenue by year
| Mar 2017 | ₹40.00 Cr |
|---|---|
| Mar 2018 | ₹42.00 Cr |
| Mar 2019 | ₹48.00 Cr |
| Mar 2020 | ₹50.00 Cr |
| Mar 2021 | ₹49.00 Cr |
| Mar 2022 | ₹69.00 Cr |
| Mar 2023 | ₹103 Cr |
| Mar 2024 | ₹105 Cr |
| Mar 2025 | ₹107 Cr |
| Mar 2026 | ₹107 Cr |
Net profit by year
| Mar 2017 | ₹3.00 Cr |
|---|---|
| Mar 2018 | ₹4.00 Cr |
| Mar 2019 | ₹4.00 Cr |
| Mar 2020 | ₹5.00 Cr |
| Mar 2021 | ₹5.00 Cr |
| Mar 2022 | ₹8.00 Cr |
| Mar 2023 | ₹14.00 Cr |
| Mar 2024 | ₹14.00 Cr |
| Mar 2025 | ₹14.00 Cr |
| Mar 2026 | ₹11.00 Cr |
Quarterly Results
₹ Cr| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 24.63 | 23.71 | 25.61 | 31.27 | 26.05 | 27.18 | 26.24 | 28.37 | 23.56 | 25.32 | 26.73 | 31.07 | 24.67 |
| Expenses | 19.75 | 19.28 | 20.7 | 26.54 | 21.62 | 22.05 | 21.7 | 23.6 | 19.81 | 21.82 | 22.95 | 28.64 | 21.35 |
| Operating Profit | 4.88 | 4.43 | 4.91 | 4.73 | 4.43 | 5.13 | 4.54 | 4.77 | 3.75 | 3.5 | 3.78 | 2.43 | 3.32 |
| OPM % | 19.81% | 18.68% | 19.17% | 15.13% | 17.01% | 18.87% | 17.3% | 16.81% | 15.92% | 13.82% | 14.14% | 7.82% | 13.46% |
| Other Income | 0.1 | 1.01 | 1.22 | 0.13 | 0.74 | 0.7 | 0.96 | 0 | 0.66 | 0.64 | 1.06 | 1.25 | 0.52 |
| Interest | 0.07 | 0.11 | 0.05 | 0.05 | 0.06 | 0.14 | 0.08 | 0.09 | 0.06 | 0.08 | 0.09 | 0.04 | 0.08 |
| Depreciation | 0.38 | 0.41 | 0.39 | 0.56 | 0.54 | 0.56 | 0.58 | 0.51 | 0.56 | 0.58 | 0.6 | 0.59 | 0.65 |
| PBT | 4.53 | 4.92 | 5.69 | 4.25 | 4.57 | 5.13 | 4.84 | 4.17 | 3.79 | 3.48 | 4.15 | 3.05 | 3.11 |
| Tax % | 25.17% | 25.2% | 25.13% | 34.59% | 24.95% | 26.12% | 24.17% | 23.98% | 25.07% | 25% | 11.33% | 43.93% | 25.72% |
| Net Profit | 3.39 | 3.69 | 4.26 | 2.78 | 3.43 | 3.79 | 3.67 | 3.17 | 2.85 | 2.61 | 3.68 | 1.7 | 2.31 |
| EPS (₹) | 2.88 | 3.13 | 3.62 | 2.11 | 2.6 | 2.88 | 2.79 | 2.41 | 2.16 | 1.98 | 2.79 | 1.29 | 1.75 |
Profit & Loss
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 36 | 40 | 40 | 42 | 48 | 50 | 49 | 69 | 103 | 105 | 107 | 107 | 108 |
| Expenses | 31 | 34 | 33 | 35 | 41 | 42 | 41 | 56 | 83 | 86 | 90 | 93 | 95 |
| Operating Profit | 5 | 6 | 7 | 7 | 7 | 9 | 9 | 13 | 20 | 19 | 18 | 14 | 13 |
| OPM % | 13% | 14% | 17% | 16% | 14% | 17% | 18% | 19% | 19% | 18% | 16% | 13% | 12% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 3 | 4 | 3 |
| Interest | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 |
| PBT | 3 | 4 | 5 | 5 | 6 | 7 | 7 | 11 | 19 | 19 | 18 | 14 | 14 |
| Tax % | 32% | 27% | 36% | 29% | 29% | 28% | 31% | 27% | 26% | 27% | 24% | 25% | — |
| Net Profit | 2 | 3 | 3 | 4 | 4 | 5 | 5 | 8 | 14 | 14 | 14 | 11 | 10 |
| EPS (₹) | 1.9 | 3.04 | 3.21 | 3.67 | 4.04 | 5.29 | 5.01 | 8.33 | 11.94 | 10.71 | 10.47 | 8.22 | 7.81 |
| Div. Payout % | 13% | 17% | 16% | 14% | 12% | 0% | 20% | 18% | 7% | 7% | 8% | 39% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 10 | 12 | 13 | 13 | 13 |
| Reserves | 13 | 16 | 19 | 22 | 25 | 30 | 35 | 37 | 84 | 112 | 121 | 128 |
| Borrowings | 7 | 5 | 7 | 6 | 5 | 4 | 4 | 4 | 6 | 6 | 5 | 6 |
| Other Liabilities | 8 | 11 | 9 | 12 | 9 | 12 | 14 | 22 | 21 | 28 | 24 | 25 |
| Total Liabilities | 33 | 37 | 39 | 44 | 44 | 52 | 58 | 74 | 123 | 159 | 163 | 172 |
| Fixed Assets | 7 | 7 | 8 | 7 | 7 | 6 | 7 | 7 | 8 | 14 | 18 | 20 |
| CWIP | 0 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 4 | 6 | 15 | 17 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 |
| Other Assets | 26 | 28 | 30 | 36 | 36 | 44 | 49 | 65 | 111 | 137 | 131 | 135 |
| Total Assets | 33 | 37 | 39 | 44 | 44 | 52 | 58 | 74 | 123 | 159 | 163 | 172 |
Cash Flow
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 1 | 3 | 1 | 3 | 2 | 5 | 5 | −2 | 0 | 10 | 4 | 10 |
| Investing | −1 | −2 | −2 | −1 | −1 | −2 | −1 | 0 | −34 | −7 | −16 | −7 |
| Financing | 0 | −1 | 1 | −2 | −2 | −1 | −2 | −1 | 36 | 16 | −5 | −4 |
| Net Cash Flow | 0 | −1 | 0 | 0 | 0 | 1 | 3 | −2 | 1 | 18 | −18 | −1 |
| Free Cash Flow | 0 | 0 | −1 | 2 | 1 | 4 | 3 | −3 | −4 | 0 | −12 | 3 |
| CFO/OP | 46 | 69 | 45 | 79 | 63 | 73 | 85 | 5 | 28 | 82 | 48 | 103 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 142 | 134 | 138 | 170 | 137 | 164 | 140 | 172 | 137 | 137 | 119 | 134 |
| Inventory Days | 154 | 155 | 185 | 185 | 164 | 186 | 246 | 237 | 181 | 211 | 246 | 230 |
| Days Payable | 80 | 109 | 83 | 124 | 73 | 111 | 152 | 158 | 89 | 114 | 88 | 90 |
| Cash Conversion Cycle | 216 | 181 | 240 | 231 | 229 | 239 | 235 | 251 | 230 | 234 | 276 | 274 |
| Working Capital Days | 136 | 138 | 137 | 150 | 155 | 170 | 167 | 192 | 173 | 178 | 204 | 203 |
| ROCE % | 14% | 19% | 20% | 18% | 18% | 20% | 19% | 25% | 26% | 17% | 14% | 10% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Panchsheel Organics insights
39 extracted metrics across FY15–FY27.
Documents
- 1 Oct 2026
- 20 Aug 2026
- 10 Aug 2026
- 27 May 2025
- 27 Feb 2024
- General announcements 24 Oct 2026
- General announcements 6 Oct 2026
- General announcements 5 Oct 2026
Frequently Asked Questions about Panchsheel Organics
What does Panchsheel Organics Ltd do?
Incorporated in 1990, Panchsheel Organics Ltd is a manufacturer of Bulk Drug and Intermediate
Where is Panchsheel Organics Ltd (PANCHSHEEL) listed?
Panchsheel Organics Ltd trades under code 531726 on the BSE.
Which sector does Panchsheel Organics Ltd belong to?
Panchsheel Organics Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the PE ratio of Panchsheel Organics Ltd?
Panchsheel Organics Ltd trades at a PE ratio of 13.00 as of 4 Nov 2026, on earnings per share of ₹7.81, against a book value of ₹106.92 per share.
What is the 52-week high and low of Panchsheel Organics Ltd?
Over the last 52 weeks Panchsheel Organics Ltd has traded between ₹86.1 and ₹154.4 as of 4 Nov 2026.
Does Panchsheel Organics Ltd pay dividends?
Panchsheel Organics Ltd has a dividend yield of 0.79%.
What is the Return on Equity (ROE) of Panchsheel Organics Ltd?
Panchsheel Organics Ltd reported a return on equity of 7.89%. Its debt-to-equity ratio is 0.04.
Company Information
Incorporated in 1990, Panchsheel Organics Ltd is a manufacturer of Bulk Drug and Intermediate
Website panchsheelorganics.com
CEO Mr. Mahendra Abhaychand Turakhia B.Sc.
Employees 185
Face Value ₹10
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/531726.md for Panchsheel Organics Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.